The benefits of trastuzumab in the treatment of HER2+ breast cancer as a function of exposure time

Name: The benefits of trastuzumab in the treatment of HER2+ breast cancer as a function of exposure time
Creator: Felipe Andrés Cordero da Luz
Published: 2022-02-11T15:43:19.913Z
Keywords: Breast Cancer, Antineoplastic Agent, Trastuzumab, HER2-Positive Breast Cancer, Prognosis

Luz, Felipe Andrés Cordero da; Marinho, Eduarda; Nascimento, Camila; Marques, Lara; Delfino, Patrícia; Antonioli, Rafael; Silva, Marcelo; Araújo, Rogério

doi:10.17632/t3yb6fy69b.4

The benefits of trastuzumab in the treatment of HER2+ breast cancer as a function of exposure time

Published: 11 February 2022| Version 4 | DOI: 10.17632/t3yb6fy69b.4

Contributors:

Felipe Andrés Cordero da Luz, Eduarda Marinho, Camila Nascimento, Lara Marques, Patrícia Delfino, Rafael Antonioli, Marcelo Silva, Rogério Araújo

Description

Dataset for the paper "The benefits of trastuzumab in the treatment of HER2+ breast cancer as a function of exposure time", DOI: 10.3332/ecancer.2022.1347

The benefits of trastuzumab in the treatment of HER2+ breast cancer as a function of exposure time

Description

Files

Categories

Related Links

Licence